SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination

Journal

  • Cell Research

    Cell Research 32 (3), 322-324, 2022-01-20

    Springer Science and Business Media LLC

Citations (2)*help

See more

Report a problem

Back to top